In lung cancer, the effect of the epigenetic modulation of SPARC is poorly investigated; by contrast, more data are available about the role of SPARC protein in the neoplastic lung context, where it appears heterogeneously expressed in NSCLC tissues, with predominant localization in the tumor-associated-stroma. The gene discussed is SPARC; the disease is lung cancer.